Cargando…
A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis
BACKGROUND: Transcription factor retinoic acid‐related orphan receptor 2 (RORC2/RORγT) mediates interleukin (IL)‐17A and IL‐17F expression. IL‐17A plays a central role in the pathogenesis of several inflammatory disorders, including psoriasis. The RORC2 inhibitor PF‐06763809 has been hypothesized to...
Autores principales: | Berstein, G., Zhang, Y., Berger, Z., Kieras, E., Li, G., Samuel, A., Yeoh, T., Dowty, H., Beaumont, K., Wigger‐Alberti, W., von Mackensen, Y., Kroencke, U., Hamscho, R., Garcet, S., Krueger, J. G., Banfield, C., Oemar, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756278/ https://www.ncbi.nlm.nih.gov/pubmed/32767679 http://dx.doi.org/10.1111/ced.14412 |
Ejemplares similares
-
First prototype of the HLT-RORC
Publicado: (2004) -
First prototype of the HLT-RORC
Publicado: (2004) -
ALICE HLT-RORC with DDL interface
Publicado: (2004) -
A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
por: Xi, Li, et al.
Publicado: (2022) -
The C-RORC PCIe Card and its Application in the ALICE and ATLAS Experiments
por: Engel, H, et al.
Publicado: (2014)